Mail

UK markets closed

FTSE 100
7,895.85
+18.80(+0.24%)
FTSE 250
19,391.30
-59.37(-0.31%)
AIM
745.67
+0.38(+0.05%)
GBP/EUR
1.1607
-0.0076(-0.65%)
GBP/USD
1.2370
-0.0068(-0.55%)
Bitcoin GBP
51,726.82
+1,829.36(+3.67%)

11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

Evaxion Biotech A/S (EVAX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

4.3100

+0.0900

(+2.13%)

At close: 04:00PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	22.48M
Enterprise value	27.76M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	161.39
Price/book (mrq)	N/A
Enterprise value/revenue	380.33
Enterprise value/EBITDA	-1.30

Trading information

Stock price history

Beta (5Y monthly)	-0.02
52-week change ³	-69.21%
S&P500 52-week change ³	20.07%
52-week high ³	18.5000
52-week low ³	2.8240
50-day moving average ³	3.5838
200-day moving average ³	7.3289

Share statistics

Avg vol (3-month) ³	681.24k
Avg vol (10-day) ³	39.4k
Shares outstanding ⁵	5.22M
Implied shares outstanding ⁶	37.91M
Float ⁸	36.13M
% held by insiders ¹	16.60%
% held by institutions ¹	0.93%
Shares short (28 Mar 2024) ⁴	42.58k
Short ratio (28 Mar 2024) ⁴	1.23
Short % of float (28 Mar 2024) ⁴	1.18%
Short % of shares outstanding (28 Mar 2024) ⁴	0.82%
Shares short (prior month 29 Feb 2024) ⁴	27.52k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	1:10
Last split date ³	22 Jan 2024

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	-5,978.08%

Management effectiveness

Return on assets (ttm)	-79.47%
Return on equity (ttm)	-1,238.11%

Income statement

Revenue (ttm)	73k
Revenue per share (ttm)	0.03
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-21.8M
Net income avi to common (ttm)	-22.12M
Diluted EPS (ttm)	-8.1000
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	5.58M
Total cash per share (mrq)	0.11
Total debt (mrq)	10.87M
Total debt/equity (mrq)	N/A
Current ratio (mrq)	1.18
Book value per share (mrq)	-1.25

Cash flow statement

Operating cash flow (ttm)	-17.69M
Levered free cash flow (ttm)	-9.12M